This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269. doi:10.1038/s41586-020-2008-3WuFZhaoSYuBet alA new coronavirus associated with human respiratory disease in ChinaNature2020579779826526910.1038/s41586-020-2008-3Open DOISearch in Google Scholar
Bikdeli B, Madhavan M V., Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol. 2020;75(23). doi:10.1016/j.jacc.2020.04.031BikdeliBMadhavanM V.JimenezDet alCOVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-upJ Am Coll Cardiol2020752310.1016/j.jacc.2020.04.031Open DOISearch in Google Scholar
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):20332040. doi:10.1182/blood.2020006000ConnorsJMLevyJHCOVID-19 and its implications for thrombosis and anticoagulationBlood2020135232033204010.1182/blood.2020006000Open DOISearch in Google Scholar
Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast during an Emergency Response. JAMA - J Am Med Assoc. Published online, 2020. doi:10.1001/jama.2020.4031GrasselliGPesentiACecconiMCritical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast during an Emergency Response. JAMA - J Am Med AssocPublished online202010.1001/jama.2020.4031Open DOISearch in Google Scholar
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centred, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5YangXYuYXuJet alClinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centred, retrospective, observational studyLancet Respir Med20208547548110.1016/S2213-2600(20)30079-5Open DOISearch in Google Scholar
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. Published online 2020:2012-2022. doi:10.1056/nejmoa2004500BhatrajuPKGhassemiehBJNicholsMet alCovid-19 in Critically Ill Patients in the Seattle Region — Case SeriesN Engl J Med. Published online20202012-202210.1056/nejmoa2004500Open DOISearch in Google Scholar
Engelmann B, Massberg S. Thrombosis as an intravascular efector of innate immunity. Nat Rev Immunol. 2013;13(1):3445. doi:10.1038/nri3345EngelmannBMassbergSThrombosis as an intravascular efector of innate immunityNat Rev Immunol2013131344510.1038/nri3345Open DOISearch in Google Scholar
Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care. 2017;7(1):1-14. doi:10.1186/s13613-017-0339-5DelabrancheXHelmsJMezianiFImmunohaemostasis: a new view on haemostasis during sepsisAnn Intensive Care20177111410.1186/s13613-017-0339-5Open DOISearch in Google Scholar
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032GuanWNiZHuYet alClinical characteristics of coronavirus disease 2019 in ChinaN Engl J Med2020382181708172010.1056/NEJMoa2002032Open DOISearch in Google Scholar
Klok FA, Kruip MJHA, van der Meer NJM, et al. incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191(April):145-147. doi:10.1016/j.thromres.2020.04.013KlokFAKruipMJHAvan derMeer NJMet alincidence of thrombotic complications in critically ill ICU patients with COVID-19Thromb Res2020191April14514710.1016/j.thromres.2020.04.013Open DOISearch in Google Scholar
Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ. Pulmonary and Cardiac Pathology in Covid-19 : The First Autopsy Series from New Orleans 1 ) Department of Pathology , LSU Health Sciences Center, New Orleans 2 ) Pathology and Laboratory Medicine Service, Southeast Louisiana Veterans Healthcare System 3. medRxiv. Published online, 2020.FoxSEAkmatbekovAHarbertJLLiGBrownJQPulmonary and Cardiac Pathology in Covid-19 : The First Autopsy Series from New Orleans 1 ) Department of Pathology , LSU Health Sciences Center, New Orleans 2 ) Pathology and Laboratory Medicine Service, Southeast Louisiana Veterans Healthcare System 3. medRxivPublished online202010.1101/2020.04.06.20050575Search in Google Scholar
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844847. doi:10.1111/jth.14768TangNLiDWangXSunZAbnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJ Thromb Haemost202018484484710.1111/jth.14768Open DOISearch in Google Scholar
Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191(April):148-150. doi:10.1016/j.thromres.2020.04.041KlokFAKruipMJHAvan derMeer NJMet alConfirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysisThromb Res2020191April14815010.1016/j.thromres.2020.04.041Open DOISearch in Google Scholar
Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.; 2020. doi:10.1182/blood.2020006520Al-SamkariHKarpLeaf RSDzikWHet alCOVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.;202010.1182/blood.2020006520Open DOISearch in Google Scholar
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;(April):1421-1424. doi:10.1111/jth.14830CuiSChenSLiXLiuSWangFPrevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJ Thromb Haemost20201421–142410.1111/jth.14830Open DOISearch in Google Scholar
Hippensteel JA, Burnham EL, Jolley SE. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19. Br J Haematol. Published online 2020:0-3. doi:10.1111/bjh.16908HippensteelJABurnhamELJolleySEPrevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19Br J Haematol. Published online20200-310.1111/bjh.16908Open DOISearch in Google Scholar
Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. Published online, 2020. doi:10.1007/s00134-020-06062-xHelmsJTacquardCSeveracFet alHigh risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care MedPublished online202010.1007/s00134-020-06062-xOpen DOISearch in Google Scholar
Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;(April):1-4. doi:10.1111/jth.14869LlitjosJFLeclercMChochoisCet alHigh incidence of venous thromboembolic events in anticoagulated severe COVID-19 patientsJ Thromb Haemost20201-410.1111/jth.14869Open DOISearch in Google Scholar
Nahum J, Morichau-Beauchant T, Daviaud F, et al. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020;3(5):e2010478. doi:10.1001/jamanetworkopen.2020.10478NahumJMorichau-BeauchantTDaviaudFet alVenous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)JAMA Netw Open202035e201047810.1001/jamanetworkopen.2020.10478Open DOISearch in Google Scholar
Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25(1):45-48. doi:10.1016/j. ejim.2013.07.012LippiGBonfantiLSaccentiCCervellinGCauses of elevated D-dimer in patients admitted to a large urban emergency departmentEur J Intern Med2014251454810.1016/j.ejim.2013.07.012Open DOISearch in Google Scholar
Bowles L, Platon S, Yartey N, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med. Published online 2020:1-2. doi:10.1056/nejmc2013656BowlesLPlatonSYarteyNet alLupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19N Engl J MedPublished online20201–210.1056/nejmc2013656Open DOISearch in Google Scholar
Harzallah I, Debliquis A, Drénou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;(April):14867. doi:10.1111/jth.14867HarzallahIDebliquisADrénouBLupus anticoagulant is frequent in patients with Covid-19J Thromb Haemost20201486710.1111/jth.14867Open DOISearch in Google Scholar
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;(March):1094-1099. doi:10.1111/jth.14817TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJ Thromb Haemost20201094–109910.1111/jth.14817Open DOISearch in Google Scholar
Wiseman AC. Immunosuppressive medications. Clin J Am Soc Nephrol. 2016;11(2):332-343. doi:10.2215/CJN.08570814WisemanACImmunosuppressive medicationsClin J Am Soc Nephrol201611233234310.2215/CJN.08570814Open DOISearch in Google Scholar
Journal EH, Pharmacotherapy C. Figure 1. Published online 2020:1-2. doi:10.1111/jth.14817.6.JournalEHPharmacotherapyCFigure 1Published online20201–210.1111/jth.14817.6Open DOISearch in Google Scholar
Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;(March):1023-1026. doi:10.1111/jth.14810ThachilJTangNGandoSet alISTH interim guidance on recognition and management of coagulopathy in COVID-19J Thromb Haemost20201023–102610.1111/jth.14810Open DOISearch in Google Scholar
Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. J Thromb Haemost. Published online 2020:0-2. doi:10.1111/jth.14929SpyropoulosACLevyJHAgenoWet alScientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19J Thromb HaemostPublished online20200–210.1111/jth.14929Open DOISearch in Google Scholar
Barnes GD, Burnet A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;(0123456789):1-10. doi:10.1007/s11239-020-02138-zBarnesGDBurnetAAllenAet alThromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forumJ Thromb Thrombolysis202001234567891–1010.1007/s11239-020-02138-zOpen DOISearch in Google Scholar
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7ChenNZhouMDongXet alEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/S0140-6736(20)30211-7Open DOISearch in Google Scholar
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585WangDHuBHuCet alClinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, ChinaJAMA - J Am Med Assoc2020323111061106910.1001/jama.2020.1585Open DOISearch in Google Scholar
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):10541062. doi:10.1016/S0140-6736(20)30566-3ZhouFYuTDuRet alClinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet2020395102291054106210.1016/S0140-6736(20)30566-3Open DOISearch in Google Scholar
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5HuangCWangYLiXet alClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet20203951022349750610.1016/S0140-6736(20)30183-5Open DOISearch in Google Scholar
Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-2629. doi:10.1172/JCI137244ChenGWuDGuoWet alClinical and immunological features of severe and moderate coronavirus disease 2019J Clin Invest202013052620262910.1172/JCI137244Open DOISearch in Google Scholar
Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [published online ahead of print, 2020 Mar 16]. Clin Chem Lab Med. Published online, 2020. doi:10.1515/cclm-2020-0188HanHYangLLiuRet alProminent changes in blood coagulation of patients with SARS-CoV-2 infection [published online ahead of print, 2020 Mar 16]Clin Chem Lab MedPublished online202010.1515/cclm-2020-0188Open DOISearch in Google Scholar
Li Y, Zhao K, Wei H, et al. Dynamic relationship between D‐ dimer and COVID‐19 severity. Br J Haematol. Published online 2020:bjh.16811. doi:10.1111/bjh.16811LiYZhaoKWeiHet alDynamic relationship between D‐ dimer and COVID‐19 severityBr J Haematol. Published online2020bjh.1681110.1111/bjh.16811Open DOISearch in Google Scholar
Ashjian P, Chen CM, Pusic A, Disa JJ, Cordeiro PG, Mehrara BJ. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg. 2007;59(1):36-39. doi:10.1097/01.sap.0000264837.15110.2fAshjianPChenCMPusicADisaJJCordeiroPGMehraraBJThe effect of postoperative anticoagulation on microvascular thrombosisAnn Plast Surg2007591363910.1097/01.sap.0000264837.15110.2fOpen DOISearch in Google Scholar
Sorg H, Hofmann JO, Hofmann JN, Vollmar B. Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation. Intensive Care Med Exp. 2015;3(1):22. doi:10.1186/s40635-015-0058-xSorgHHofmannJOHofmannJNVollmarBAnalysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulationIntensive Care Med Exp2015312210.1186/s40635-015-0058-xOpen DOISearch in Google Scholar
